“…1,2 During this time, the increase in healthcare costs for pediatric stone disease has outpaced medical inflation; and the amount of healthcare dollars spent on it has quadrupled. 3,4 The shift in disease onset to childhood means that pediatric providers must evaluate and treat a previously uncommon condition with limited evidence to inform care. This increases the possibility of over or under testing, unnecessary irradiation, and inappropriate health services utilization, such as emergency department (ED) revisits.…”